Hajime Yoshifuji
Wakayama Medical University
Janus kinaseCCL5CTDInternal medicineChemokinePathologyCo-occurrenceAntibodyAutoantibodyCardiologyImmunologyT cellInterferonRheumatoid arthritisDifferential diagnosisPulmonary arteryIschemic Heart DiseasesAlpha interferonChemokine secretionProtein antibodyDiagnostic biomarkerTakayasu arteritisConnective tissueThyroidText miningMedicineCX3CL1Biology
Publications 5
#2Hajime YoshifujiH-Index: 2
Last. Akio MorinobuH-Index: 1
view all 0 authors...
#1Toshiki NakajimaH-Index: 8
#2Hajime YoshifujiH-Index: 2
Last. Tsuneyo MimoriH-Index: 1
view all 11 authors...
#1Shuichiro Nakabo (Kyoto University)H-Index: 10
#2Hajime Yoshifuji (Wakayama Medical University)H-Index: 2
Last. Koichiro OhmuraH-Index: 35
view all 13 authors...
Objective. Anti-carbamylated protein (anti-CarP) antibodies are possible diagnostic biomarkers of anticitrullinated protein antibody (ACPA)-negative rheumatoid arthritis (RA). We aimed to elucidate the prevalence of anti-CarP antibodies in non-RA connective tissue diseases (CTD) because CTD are important in the differential diagnosis of ACPA-negative RA. Methods. The sera from 266 patients with RA and 616 patients with CTD and 80 healthy controls were examined using an in-house anti-CarP ELISA. ...
10 CitationsSource
#1M. NakanoH-Index: 2
#2Takao Fujii (Kyoto University)H-Index: 32
Last. Tsuneyo Mimori (Kyoto University)H-Index: 77
view all 8 authors...
Type I interferon (IFN) medications cause various adverse reactions, including vascular diseases. Although an association between chemokines and vascular diseases has also been reported, the relationship between type I IFN and chemokines in vascular endothelial cells (VEC) remains unclear. To provide clues to pathogenesis of the diseases, we analysed the effects of type I IFN on chemokine production in human VEC. Type I IFN induced higher CX3CL1 (fractalkine) mRNA expression and protein secretio...
23 CitationsSource